CLINICAL_TRIALS
trial_result
· 2021-06-08
Clinical Trial Update: 111In-ch806 in Patients With Advanced Tumours Expressing the 806 Antigen [Phase 1]
Summary
Phase 1 trial update of 111In-ch806 in patients with advanced tumours expressing the 806 antigen; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ludwig Institute for Cancer Research | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2021-06-08